Ieq Capital LLC Purchases Shares of 31,528 HealthEquity, Inc. $HQY

Ieq Capital LLC purchased a new position in HealthEquity, Inc. (NASDAQ:HQY) in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 31,528 shares of the company’s stock, valued at approximately $2,848,000.

Several other institutional investors and hedge funds have also recently modified their holdings of the company. Callan Family Office LLC purchased a new position in shares of HealthEquity during the 2nd quarter valued at $718,000. Keebeck Wealth Management purchased a new stake in HealthEquity in the 2nd quarter worth $457,000. Keating Financial Advisory Services Inc. bought a new stake in HealthEquity during the second quarter valued at about $234,000. Paralel Advisors LLC bought a new stake in HealthEquity during the second quarter valued at about $2,498,000. Finally, Allworth Financial LP purchased a new position in shares of HealthEquity in the second quarter valued at about $223,000. 99.55% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

A number of equities analysts have recently weighed in on the company. Citigroup reaffirmed a “market outperform” rating on shares of HealthEquity in a research note on Monday, June 1st. Royal Bank Of Canada boosted their price target on HealthEquity from $100.00 to $108.00 and gave the stock an “outperform” rating in a report on Wednesday, June 3rd. Wall Street Zen raised shares of HealthEquity from a “hold” rating to a “buy” rating in a report on Saturday. KeyCorp reissued an “overweight” rating on shares of HealthEquity in a report on Tuesday, May 26th. Finally, Citizens Jmp raised their target price on shares of HealthEquity from $110.00 to $111.00 and gave the company a “market outperform” rating in a research note on Monday, June 1st. Eleven investment analysts have rated the stock with a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $110.93.

Insider Activity

In other news, EVP Michael Henry Fiore sold 3,142 shares of the business’s stock in a transaction that occurred on Friday, May 29th. The stock was sold at an average price of $95.00, for a total transaction of $298,490.00. Following the transaction, the executive vice president owned 59,113 shares of the company’s stock, valued at approximately $5,615,735. The trade was a 5.05% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Gayle Furgurson Wellborn sold 2,439 shares of the firm’s stock in a transaction on Thursday, May 28th. The stock was sold at an average price of $90.00, for a total value of $219,510.00. Following the completion of the sale, the director owned 19,733 shares of the company’s stock, valued at approximately $1,775,970. This represents a 11.00% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders have sold 17,905 shares of company stock valued at $1,651,280. 1.60% of the stock is currently owned by insiders.

HealthEquity Stock Performance

Shares of NASDAQ:HQY opened at $105.40 on Tuesday. The firm has a fifty day simple moving average of $97.01 and a two-hundred day simple moving average of $87.37. HealthEquity, Inc. has a 52 week low of $72.76 and a 52 week high of $107.62. The company has a quick ratio of 3.44, a current ratio of 3.44 and a debt-to-equity ratio of 0.46. The stock has a market capitalization of $8.81 billion, a P/E ratio of 39.48, a PEG ratio of 1.77 and a beta of 0.21.

HealthEquity (NASDAQ:HQY) last announced its quarterly earnings results on Thursday, May 28th. The company reported $1.24 EPS for the quarter, beating analysts’ consensus estimates of $1.11 by $0.13. HealthEquity had a net margin of 17.25% and a return on equity of 14.75%. The firm had revenue of $354.64 million during the quarter, compared to the consensus estimate of $352.02 million. The company’s revenue was up 7.2% on a year-over-year basis. HealthEquity has set its FY 2027 guidance at 2.880-2.950 EPS. On average, analysts expect that HealthEquity, Inc. will post 3.92 earnings per share for the current fiscal year.

About HealthEquity

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.